TrialPanorama/TrialPanorama-database huggingface dataset:
Study 29206944 — Predictive Biomarker (PRD): INHBA mRNA
Genes: INHBA
Study 29206944 — Predictive Biomarker (PRD): CYP19A1 mRNA
Genes: CYP19A1; ARO1; CYAR; CYP19
Study 29206944 — Predictive Biomarker (PRD): HSD3B2 mRNA
Genes: HSD3B2; HSDB3B
Study 29207608 — Predictive Biomarker (PRD): GSTA1 mRNA
Genes: GSTA1
Study 29207983 — Surrogate Endpoint (SUR): Blood pressure
Study 29209104 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 29209104 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 29209525 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 29209636 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Chitinase-3-like protein 1
Genes: CHI3L1
Study 29209946 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 29209946 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 29211618 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 29211870 — Surrogate Endpoint (SUR): Serum calcium
Study 29212126 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 29212734 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 29213243 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study 29213269 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 29214012 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 29214034 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 29216353 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 29216353 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 29216356 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 29216356 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 29216356 — Monitoring Biomarker (MOI): Cell-free DNA
Study 29216400 — Predictive Biomarker (PRD): TFE3 mRNA
Genes: TFE3; BHLHE33
Study 29216400 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 29217288 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 29220505 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 29221433 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 29221433 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 29221483 — Surrogate Endpoint (SUR): Blood pressure
Study 29222199 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 29223478 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 29223478 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study 29223478 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 29224367 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 29224367 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 29224367 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study 29225901 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 29225901 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 29226174 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 29226174 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 29226764 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 29226797 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 29228942 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 29230539 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 29232153 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 29232322 — Pharmacodynamic Biomarker (PDY): Antidrug antibody
Study 29233119 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 29233821 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 29235365 — Surrogate Endpoint (SUR): Blood pressure
Study 29236912 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 29237655 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study 29239002 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 29239951 — Surrogate Endpoint (SUR): Blood pressure
Study 29239953 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 29241084 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 29241485 — Surrogate Endpoint (SUR): Blood pressure
Study 29241485 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 29241485 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 29241640 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 29241979 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 29242352 — Surrogate Endpoint (SUR): Blood pressure
Study 29242852 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-C
Genes: HLA-JY3, D6S204, PSORS1
Study 29243075 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study 29244126 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 29244149 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 29244957 — Predictive Biomarker (PRD): ENPP1 mRNA
Genes: ENPP1; M6S1; NPPS; PC1; PDNP1
Study 29245310 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 29246151 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 29246159 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 29246803 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 29246803 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 29247021 — Predictive Biomarker (PRD): MAPK3 mRNA
Genes: MAPK3; ERK1; PRKM3
Study 29247063 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 29247830 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 29247830 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 29247830 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 29248236 — Surrogate Endpoint (SUR): Serum testosterone
Study 29248319 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 29248621 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 29248894 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 29251556 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 29251709 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 29252124 — Pharmacodynamic Biomarker (PDY): DNA topoisomerase I
Genes: TOP1
Study 29253081 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 29253097 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 29253846 — Surrogate Endpoint (SUR): Blood pressure
Study 29253846 — Surrogate Endpoint (SUR): Serum creatinine
Study 29253918 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 29254506 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 29257710 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 29257710 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 29258560 — Predictive Biomarker (PRD): CSN3 mRNA
Genes: CSN3; CASK; CSN10; CSNK
Study 29258585 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study 29258585 — Safety Biomarker (SAF): Cytochrome c
Study 29258618 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 29258618 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 29258913 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 29258978 — Surrogate Endpoint (SUR): Blood pressure
Study 29259073 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 29259073 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 29259073 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 29259809 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TNS1 mRNA
Genes: TNS1; TNS
Study 29259998 — Predictive Biomarker (PRD): CFP mRNA
Genes: CFP; PFC
Study 29260603 — Predictive Biomarker (PRD): DCD mRNA
Genes: DCD; AIDD; DSEP
Study 29261402 — Surrogate Endpoint (SUR): Forced vital capacity
Study 29263032 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 29263032 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 29263704 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 29263894 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 29263894 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study 29267966 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 29267966 — Surrogate Endpoint (SUR): Serum sodium
Study 29268712 — Surrogate Endpoint (SUR): Blood pressure
Study 29268924 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 29269559 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 29269980 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 29270080 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 29270685 — Predictive Biomarker (PRD): CD2 mRNA
Genes: CD2; SRBC
Study 29272368 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 29272480 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 29273043 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study 29273071 — Safety Biomarker (SAF): miR-22
Genes: MIR22
Study 29273410 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 29274733 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 29274733 — Safety Biomarker (SAF): BDNF
Study 29276022 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 29276625 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 29277374 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 29279305 — Monitoring Biomarker (MOI): Mitochondrial frataxin
Genes: FXN; FRDA; X25
Study 29280762 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 29280762 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 29282109 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 29282329 — Predictive Biomarker (PRD): miR-135b
Genes: MIR135B
Study 29282329 — Safety Biomarker (SAF): miR-140
Genes: MIR140
Study 29282548 — Surrogate Endpoint (SUR): Bone mineral density
Study 29282676 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 29282676 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 29284010 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 29284010 — Predictive Biomarker (PRD): Microsatellite instability
Study 29284521 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 29284530 — Surrogate Endpoint (SUR): Blood pressure
Study 29284607 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study 29285038 — Surrogate Endpoint (SUR): Pathological complete response
Study 29290251 — Predictive Biomarker (PRD): DLL3 mRNA
Genes: DLL3
Study 29290515 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 29290515 — Surrogate Endpoint (SUR): Forced vital capacity
Study 29292843 — Predictive Biomarker (PRD): CD248 mRNA
Genes: CD248; CD164L1; TEM1
Study 29293889 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 29293942 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 29294006 — Predictive Biomarker (PRD): PDK4 mRNA
Genes: PDK4; PDHK4
Study 29294006 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 29296283 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 29296283 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study 29296710 — Monitoring Biomarker (MOI): Cell-free DNA
Study 29296707 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 29296751 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 29296751 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study 29296758 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study 29296761 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 29296798 — Predictive Biomarker (PRD): MAGEA1 mRNA
Genes: MAGEA1; MAGE1; MAGE1A
Study 29298867 — Predictive Biomarker (PRD): SH2D1A mRNA
Genes: SH2D1A; DSHP; SAP
Study 29299030 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 29299952 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 29300435 — Surrogate Endpoint (SUR): Blood pressure
Study 29300960 — Predictive Biomarker (PRD): LEPROT mRNA
Genes: LEPROT; LEPR; OBR
Study 29300960 — Predictive Biomarker (PRD): ADAM10 mRNA
Genes: ADAM10; KUZ; MADM
Study 29300960 — Predictive Biomarker (PRD): ADAM17 mRNA
Genes: ADAM17; CSVP; TACE
Study 29300991 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 29300991 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 29301628 — Predictive Biomarker (PRD): MARCKSL1 mRNA
Genes: MARCKSL1; MLP; MRP
Study 29301973 — Surrogate Endpoint (SUR): Blood pressure
Study 29302336 — Predictive Biomarker (PRD): MMRN1 mRNA
Genes: MMRN1; ECM; EMILIN4; GPIA*; MMRN
Study 29303843 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 29305315 — Predictive Biomarker (PRD): RELA mRNA
Genes: RELA; NFKB3
Study 29305315 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 29305734 — Predictive Biomarker (PRD): SMPD1 mRNA
Genes: SMPD1; ASM
Study 29305734 — Surrogate Endpoint (SUR): Bone mineral density
Study 29306459 — Surrogate Endpoint (SUR): Serum uric acid
Study 29308669 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 29309249 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 29309249 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study 29309249 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 29309629 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 29311357 — Surrogate Endpoint (SUR): Blood pressure
Study 29312786 — Surrogate Endpoint (SUR): Blood pressure
Study 29313223 — Surrogate Endpoint (SUR): Blood pressure
Study 29313282 — Surrogate Endpoint (SUR): Blood pressure
Study 29313714 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 29316001 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study 29316837 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 29316837 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 29317604 — Predictive Biomarker (PRD): DEFB1 mRNA
Genes: DEFB1; BD1; HBD1
Study 29317604 — Predictive Biomarker (PRD): AHR mRNA
Genes: AHR; BHLHE76
Study 29318647 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study 29320312 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 29320994 — Surrogate Endpoint (SUR): Blood pressure
Study 29322062 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study 29324603 — Surrogate Endpoint (SUR): Blood pressure
Study 29324603 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 29325058 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 29325434 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 29325521 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study 29326029 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 29326029 — Pharmacodynamic Biomarker (PDY): Retinoblastoma-associated protein
Genes: RB1
Study 29326031 — Predictive Biomarker (PRD): IDS mRNA
Genes: IDS; SIDS
Study 29326298 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 29326843 — Surrogate Endpoint (SUR): Serum creatinine
Study 29327075 — Surrogate Endpoint (SUR): Pathological complete response
Study 29327948 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 29327948 — Pharmacodynamic Biomarker (PDY): Nasal potential difference
Study 29329602 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 29330639 — Surrogate Endpoint (SUR): Blood pressure
Study 29331971 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 29331988 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 29332633 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 29333165 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 29333880 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study 29333880 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study 29333880 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 29333880 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 29333880 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 29333880 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 29333880 — Predictive Biomarker (PRD): HTR2A mRNA
Genes: HTR2A; HTR2
Study 29333880 — Predictive Biomarker (PRD): ADRA2A mRNA
Genes: ADRA2A; ADRA2R; ADRAR
Study 29333880 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 29333880 — Predictive Biomarker (PRD): 5HTT
Genes: SLC6A4; 5-HTT; SERT1
Study 29334265 — Surrogate Endpoint (SUR): Blood pressure
Study 29335020 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 29335020 — Predictive Biomarker (PRD): ACVR1B mRNA
Genes: ACVR1B; ACVRLK4; ALK4
Study 29335234 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 29336016 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 29338080 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 29339691 — Surrogate Endpoint (SUR): Blood pressure
Study 29342267 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study 29343156 — Surrogate Endpoint (SUR): Blood pressure
Study 29344432 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study 29345044 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 29345044 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 29346478 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study 29346833 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 29346833 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 29347987 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 29347993 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study 29347993 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 29348128 — Predictive Biomarker (PRD): NEDD8 mRNA
Genes: NEDD8
Study 29349065 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 29349065 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 29349065 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 29349545 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 29349598 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study 29349598 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 29351986 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 29351986 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 29352703 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study 29352732 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 29352732 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 29352732 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study 29353109 — Predictive Biomarker (PRD): NRM mRNA
Genes: NRM; NRM29; UNQ555/PRO1112
Study 29355075 — Predictive Biomarker (PRD): Microsatellite instability
Study 29356832 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 29361134 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 29361134 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 29361134 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 29361435 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 29361470 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 29361470 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 29361917 — Predictive Biomarker (PRD): CD68 mRNA
Genes: CD68
Study 29361917 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 29361934 — Surrogate Endpoint (SUR): Blood pressure
Study 29362665 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study 29362665 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study 29362665 — Predictive Biomarker (PRD): S100A12 mRNA
Genes: S100A12
Study 29362724 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 29362724 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 29363050 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study 29363235 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study 29363235 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 29363250 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 29363343 — Safety Biomarker (SAF): APC
Genes: DP2; DP3; DP2.5; PPP1R46